Scripps Clinic, University of California San FranciscoDisclosures
The following pharmaceutical companies are companies that Dr. Fujioka have done business with over the past 3 years. These companies have a metabolic agent or device that he has researched or have been asked to consult about. Dr. Fujioka does not sit on any of the financial boards of these companies. He also does not own individual stocks of any of these companies. Consulting is done on a scientific advisory board or steering committee. Dr. Fujioka has received research grants, consulted for or been a member of the speakers bureau for Orexigen, Novanordisk, Enteromedics, Amylin, Roche, Nastech, Trans Tech, Pfizer, Arena, Merck, Sanofi, Vivus and Lilly.
You need to be logged in to save this episode to a playlist.
You must be logged in to display playlists.